相关实验视频
Updated: Jan 14, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
2.2K
数字双胞胎和心脏衰竭中的人工智能:前提和承诺
Mandeep R Mehra1, Milica Vukićević2, Ameesh Isath1
1Mass General Brigham Heart and Vascular Institute and Harvard Medical School, Boston, MA.
Journal of cardiac failure
|January 12, 2026
概括
数字双胞胎创建个性化的患者复制品,以实时监测心力衰竭. 这项技术可以早期检测不稳定性,并通过先进的AI和模拟来改善患者护理.
科学领域:
- 心脏病学 心脏病学
- 生物医学工程 生物医学工程
- 人工智能的人工智能
背景情况:
- 心力衰竭 (HF) 管理面临着不一致的结果和延迟对临床恶化的认可的挑战.
- 传统的人工智能 (AI) 模型在人口层面上运行,未能捕捉到个体HF患者的动态生理变化.
研究的目的:
- 引入数字双胞胎技术作为一种用于推进心力衰竭护理的新方法.
- 突出数字双胞胎在实现实时,个性化的患者监测和决策方面的潜力.
主要方法:
- 数字双胞胎是个别患者的持续校准,机械地接地计算复制品.
- 整合多模式数据,包括生理,成像,临床,分子和行为信息.
- 利用基于物理的模型和先进的AI层进行实时模拟.
主要成果:
- 数字双胞胎可以预测心力衰竭的生理不稳定性.
- 潜在的应用包括试验的虚拟比较器臂,机制固的表型化和资源优化.
- 该技术将护理从反应性转变为预测性和个性化管理.
结论:
- 数字双胞胎技术为心力衰竭护理提供了变革性的转变,朝准确医学迈进.
- 负责任的实施,严格的验证,公平和透明度对于成功的翻译至关重要.
- 需要进一步的研究和基于证据的实施,才能充分发挥数字双胞胎在治疗心力衰竭等复杂综合征方面的潜力.
相关概念视频
Heart Failure VI: Adjunct Therapies
246
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
246
Issues And Trends In Healthcare Delivery System
6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Cardiomyopathy II: Dilated Cardiomyopathy
457
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
457
Heart Failure IV: Classification and Diagnostic Evaluation
313
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
313
Cardiomyopathy V: Interprofessional Care
331
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
331
Heart Failure II: Pathophysiology
704
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
704

